{"transactions":[{"id":2651631,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T19:37:26.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal quarterly installments over the next year."}],"balance_after":25000,"derivative":{"exercise_price":3.16,"exercise_date":"2021-06-28","expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-21-015614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315221015614/ownership.xml","form_type":"4"}},{"id":3030047,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-16T20:00:10.000Z","date":"2020-09-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests quarterly over the next year."}],"balance_after":25000,"derivative":{"exercise_price":3.43,"exercise_date":"2020-12-14","expiration_date":"2030-09-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-20-017931","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315220017931/ownership.xml","form_type":"4"}},{"id":3123855,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-03T21:09:54.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Compensation Committee on April 14, 2020, subject to stockholder approval of an amendment to the Issuer's 2011 Incentive Plan to increase the number of authorized shares. The Issuer's stockholders approved the plan amendment on May 29, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was 25% vested on April 14, 2020, and the remainder vests quarterly over the next three years."}],"balance_after":25000,"derivative":{"exercise_price":1.56,"exercise_date":"2020-04-14","expiration_date":"2030-04-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-20-010504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315220010504/ownership.xml","form_type":"4"}},{"id":3233645,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHAIRMAN AND CEO"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T23:30:16.000Z","date":"2020-02-29","kind":"exercise","acquired":false,"shares":5607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Issuer's 2013 Share Ownership and Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"As a result of reporting person's separation from the Issuer, 25% of all unvested equity accelerated in accordance with the reporting person's employment agreement and the remaining unvested equity was forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5607},"source":{"system":"sec-edgar","filing":"0001415889-20-000595","document":"form4-03032020_060302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000595/form4-03032020_060302.xml","form_type":"4"}},{"id":3233644,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHAIRMAN AND CEO"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T23:30:16.000Z","date":"2020-02-29","kind":"exercise","acquired":false,"shares":71199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Issuer's 2013 Share Ownership and Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"As a result of reporting person's separation from the Issuer, 25% of all unvested equity accelerated in accordance with the reporting person's employment agreement and the remaining unvested equity was forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":71199},"source":{"system":"sec-edgar","filing":"0001415889-20-000595","document":"form4-03032020_060302.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000595/form4-03032020_060302.xml","form_type":"4"}},{"id":3233643,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHAIRMAN AND CEO"}}],"security":"Common Stock","published_at":"2020-03-03T23:30:16.000Z","date":"2020-02-29","kind":"tax_withholding","acquired":false,"shares":23285,"price":3.13,"value":72882.05,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of this amount, 229,267 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":244267,"source":{"system":"sec-edgar","filing":"0001415889-20-000595","document":"form4-03032020_060302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000595/form4-03032020_060302.xml","form_type":"4"}},{"id":3233642,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHAIRMAN AND CEO"}}],"security":"Common Stock","published_at":"2020-03-03T23:30:16.000Z","date":"2020-02-29","kind":"exercise","acquired":true,"shares":76806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of this amount, 252,552 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":267552,"source":{"system":"sec-edgar","filing":"0001415889-20-000595","document":"form4-03032020_060302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000595/form4-03032020_060302.xml","form_type":"4"}},{"id":3330554,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Restricted Stock Units","published_at":"2019-12-27T21:10:15.000Z","date":"2019-12-26","kind":"exercise","acquired":false,"shares":35599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Issuer's 2013 Share Ownership and Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The remaining restricted stock units will vest ratably each quarter through December 26, 2021 subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":284794,"derivative":{"underlying":"Common Stock","underlying_shares":35599},"source":{"system":"sec-edgar","filing":"0001415889-19-001569","document":"form4-12272019_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919001569/form4-12272019_041201.xml","form_type":"4"}},{"id":3330553,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common Stock","published_at":"2019-12-27T21:10:15.000Z","date":"2019-12-26","kind":"tax_withholding","acquired":false,"shares":15806,"price":7.26,"value":114751.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of this amount, 175,746 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":190746,"source":{"system":"sec-edgar","filing":"0001415889-19-001569","document":"form4-12272019_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919001569/form4-12272019_041201.xml","form_type":"4"}},{"id":3330552,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common Stock","published_at":"2019-12-27T21:10:15.000Z","date":"2019-12-26","kind":"exercise","acquired":true,"shares":35599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of this amount, 191,552 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":206552,"source":{"system":"sec-edgar","filing":"0001415889-19-001569","document":"form4-12272019_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919001569/form4-12272019_041201.xml","form_type":"4"}},{"id":3405241,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Restricted Stock Units","published_at":"2019-09-27T20:10:15.000Z","date":"2019-09-26","kind":"exercise","acquired":false,"shares":35599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Issuer's 2013 Share Ownership and Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The remaining restricted stock units will vest ratably each quarter through December 26, 2021 subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":320393,"derivative":{"underlying":"Common Stock","underlying_shares":35599},"source":{"system":"sec-edgar","filing":"0001415889-19-001115","document":"form4-09272019_040902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919001115/form4-09272019_040902.xml","form_type":"4"}},{"id":3405240,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common Stock","published_at":"2019-09-27T20:10:15.000Z","date":"2019-09-26","kind":"tax_withholding","acquired":false,"shares":10467,"price":4.37,"value":45740.79,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of this amount, 155,953 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":170953,"source":{"system":"sec-edgar","filing":"0001415889-19-001115","document":"form4-09272019_040902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919001115/form4-09272019_040902.xml","form_type":"4"}},{"id":3405239,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common Stock","published_at":"2019-09-27T20:10:15.000Z","date":"2019-09-26","kind":"exercise","acquired":true,"shares":35599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of this amount, 166,420 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":181420,"source":{"system":"sec-edgar","filing":"0001415889-19-001115","document":"form4-09272019_040902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919001115/form4-09272019_040902.xml","form_type":"4"}},{"id":3477354,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2019-06-27T21:39:51.000Z","date":"2019-06-26","kind":"exercise","acquired":false,"shares":35599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Issuer's 2013 Share Ownership and Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The remaining restricted stock units will vest ratably each quarter through December 26, 2021 subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":355992,"derivative":{"underlying":"Common Stock","underlying_shares":35599},"source":{"system":"sec-edgar","filing":"0001415889-19-000806","document":"form4-06272019_020637.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000806/form4-06272019_020637.xml","form_type":"4"}},{"id":3477353,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2019-06-27T21:39:51.000Z","date":"2019-06-26","kind":"tax_withholding","acquired":false,"shares":10467,"price":9.03,"value":94517.01,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of this amount, 130,821 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":145821,"source":{"system":"sec-edgar","filing":"0001415889-19-000806","document":"form4-06272019_020637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000806/form4-06272019_020637.xml","form_type":"4"}},{"id":3477352,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2019-06-27T21:39:51.000Z","date":"2019-06-26","kind":"exercise","acquired":true,"shares":35599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of this amount, 141,288 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":156288,"source":{"system":"sec-edgar","filing":"0001415889-19-000806","document":"form4-06272019_020637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000806/form4-06272019_020637.xml","form_type":"4"}},{"id":3575825,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2019-03-28T20:15:14.000Z","date":"2019-03-26","kind":"exercise","acquired":false,"shares":35599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Issuer's 2013 Share Ownership and Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The remaining restricted stock units will vest ratably each quarter through December 26, 2021 subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":391591,"derivative":{"underlying":"Common Stock","underlying_shares":35599},"source":{"system":"sec-edgar","filing":"0001415889-19-000399","document":"form4-03282019_040301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000399/form4-03282019_040301.xml","form_type":"4"}},{"id":3575824,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2019-03-28T20:15:14.000Z","date":"2019-03-26","kind":"tax_withholding","acquired":false,"shares":10467,"price":11.5,"value":120370.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Of this amount, 105,689 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":120689,"source":{"system":"sec-edgar","filing":"0001415889-19-000399","document":"form4-03282019_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000399/form4-03282019_040301.xml","form_type":"4"}},{"id":3575823,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2019-03-28T20:15:14.000Z","date":"2019-03-26","kind":"exercise","acquired":true,"shares":35599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of this amount, 116,156 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":131156,"source":{"system":"sec-edgar","filing":"0001415889-19-000399","document":"form4-03282019_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000399/form4-03282019_040301.xml","form_type":"4"}},{"id":3681474,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock Options","published_at":"2019-02-01T00:42:33.000Z","date":"2019-01-30","kind":"grant","acquired":true,"shares":226000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on January 30, 2020, and the remainder vests in twelve equal quarterly installments thereafter."}],"balance_after":226000,"derivative":{"exercise_price":11.53,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":226000},"source":{"system":"sec-edgar","filing":"0001415889-19-000110","document":"form4-01312019_040118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000110/form4-01312019_040118.xml","form_type":"4"}},{"id":3703866,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T21:01:57.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This is a long-term equity incentive award of stock options which will vest quarterly over the next three years. The first vesting will occur on 1/31/2019, and the award will be fully vested on 10/31/2021 pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":50000,"derivative":{"exercise_price":0.655,"exercise_date":"2019-01-31","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-19-000206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315219000206/ownership.xml","form_type":"4"}},{"id":3716939,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Units","published_at":"2018-12-28T21:15:16.000Z","date":"2018-12-26","kind":"exercise","acquired":false,"shares":213595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The restricted stock units were issued pursuant to the Issuer's 2013 Share Ownership and Option Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"The remaining restricted stock units will vest ratably each quarter over the next three years, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":427190,"derivative":{"underlying":"Common Stock","underlying_shares":213595},"source":{"system":"sec-edgar","filing":"0001415889-18-001856","document":"form4-12282018_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588918001856/form4-12282018_041201.xml","form_type":"4"}},{"id":3716938,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2018-12-28T21:15:16.000Z","date":"2018-12-28","kind":"gift","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Gift from the Robert E. Ward 2017 Revocable Trust to a family charitable  foundation of which Mr. Ward is an officer, but he is not deemed to hold a pecuniary interest in the foundation."},{"field":"shares","element":"transactionShares","label":"F4","text":"The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Reflects 80,557 shares held in the Robert E. Ward 2017 Revocable Trust."}],"balance_after":95557,"source":{"system":"sec-edgar","filing":"0001415889-18-001856","document":"form4-12282018_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588918001856/form4-12282018_041201.xml","form_type":"4"}},{"id":3716937,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2018-12-28T21:15:16.000Z","date":"2018-12-26","kind":"tax_withholding","acquired":false,"shares":83038,"price":12.6,"value":1046278.8,"ownership":{"direct":true},"balance_after":145557,"source":{"system":"sec-edgar","filing":"0001415889-18-001856","document":"form4-12282018_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588918001856/form4-12282018_041201.xml","form_type":"4"}},{"id":3716936,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2018-12-28T21:15:16.000Z","date":"2018-12-26","kind":"exercise","acquired":true,"shares":213595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on December 26, 2017 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of this amount, 130,557 shares have been transferred to the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee."}],"balance_after":228595,"source":{"system":"sec-edgar","filing":"0001415889-18-001856","document":"form4-12282018_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588918001856/form4-12282018_041201.xml","form_type":"4"}},{"id":3769473,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-09T16:30:48.000Z","date":"2018-11-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting in 12 equal monthly increments, with the first 1/12th vesting on the first monthly anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":100000,"derivative":{"exercise_price":0.84,"exercise_date":"2018-12-08","expiration_date":"2028-12-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-18-015582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218015582/ownership.xml","form_type":"4"}},{"id":3920844,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-23T20:17:14.000Z","date":"2018-05-22","kind":"purchase","acquired":true,"shares":5000,"price":14.34,"value":71700.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-18-032580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118032580/doc4.xml","form_type":"4"}},{"id":3983231,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-26T21:13:51.000Z","date":"2018-03-23","kind":"purchase","acquired":true,"shares":10000,"price":8.99,"value":89900.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-18-021645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118021645/doc4.xml","form_type":"4"}},{"id":4120393,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-12-28T21:46:40.000Z","date":"2017-12-26","kind":"grant","acquired":false,"shares":640785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The time-vesting options vest and become exercisable over a four (4) year period commencing on the Effective Date, with one-third (1/3) of the shares of common stock underlying the options vesting on December 26, 2018, with an additional one-twelfth (1/12) of the shares underlying the options vesting on each quarterly anniversary of the Effective Date over the course of three (3) years, subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer; provided that vesting will be accelerated following the achievement of certain milestones."}],"balance_after":640785,"derivative":{"exercise_price":8,"expiration_date":"2027-12-26","underlying":"Common Stock","underlying_shares":640785},"source":{"system":"sec-edgar","filing":"0001144204-17-065647","document":"tv482219_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114420417065647/tv482219_4.xml","form_type":"4"}},{"id":4120392,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-12-28T21:46:40.000Z","date":"2017-12-26","kind":"grant","acquired":false,"shares":640785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The time-vesting restricted stock units vest and become exercisable over a four (4) year period commencing on December 26, 2017 (the \"Effective Date\"), with one-third (1/3) of the units vesting on December 26, 2018, with an additional one-twelfth (1/12) of the units vesting on each quarterly anniversary of the Effective Date over the course of three (3) years, subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer; provided that vesting will be accelerated following the achievement of certain milestones."}],"balance_after":640785,"derivative":{"expiration_date":"2027-12-26","underlying":"Common Stock","underlying_shares":640785},"source":{"system":"sec-edgar","filing":"0001144204-17-065647","document":"tv482219_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114420417065647/tv482219_4.xml","form_type":"4"}},{"id":4120391,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-12-28T21:46:40.000Z","date":"2017-12-26","kind":"grant","acquired":false,"shares":22427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The performance stock options vest and become immediately exercisable upon the date that marks the Issuer's first successful completion of a Phase-2B study with respect to any indication, subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer."}],"balance_after":22427,"derivative":{"exercise_price":8,"expiration_date":"2027-12-26","underlying":"Common Stock","underlying_shares":22427},"source":{"system":"sec-edgar","filing":"0001144204-17-065647","document":"tv482219_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114420417065647/tv482219_4.xml","form_type":"4"}},{"id":4120390,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-12-28T21:46:40.000Z","date":"2017-12-26","kind":"grant","acquired":false,"shares":22427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The performance restricted stock units vest and become immediately exercisable upon the date that marks the Issuer's first successful completion of a Phase-2B study with respect to any indication, subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer."}],"balance_after":22427,"derivative":{"expiration_date":"2027-12-26","underlying":"Common Stock","underlying_shares":22427},"source":{"system":"sec-edgar","filing":"0001144204-17-065647","document":"tv482219_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000114420417065647/tv482219_4.xml","form_type":"4"}},{"id":4431352,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-22T16:31:06.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":187800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on February 17, 2018 and the remaining shares shall vest in substantially equal monthly installments over the following three years."}],"balance_after":187800,"derivative":{"exercise_price":45.65,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":187800},"source":{"system":"sec-edgar","filing":"0001209191-17-013274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000120919117013274/doc4.xml","form_type":"4"}},{"id":4574790,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-25T21:54:46.000Z","date":"2016-10-25","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price and number of derivative securities was adjusted to reflect the stock split that occurred on April 24, 2014."},{"field":"shares","element":"transactionShares","label":"F1","text":"The exercise price and number of derivative securities was adjusted to reflect the stock split that occurred on April 24, 2014."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option vested as to 25% of the underlying shares upon consummation of the Issuer's initial public offering on June 6, 2014 and as to an additional 18.75% of the underlying shares on December 16, 2014. The remainder of the stock option vests in substantially equal installments on the 16th day of each of the 36 consecutive months beginning January 16, 2015."}],"balance_after":733785,"derivative":{"exercise_price":7.8,"expiration_date":"2024-02-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-16-152030","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000110465916152030/a4.xml","form_type":"4"}},{"id":4574789,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":137774,"kind":"person","name":"Ward Robert","position":1,"cik":"0001595111","reported_name":"Ward Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-10-25T21:54:46.000Z","date":"2016-10-25","kind":"exercise","acquired":true,"shares":10000,"price":7.8,"value":78000.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001104659-16-152030","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1428522/000110465916152030/a4.xml","form_type":"4"}}]}